# Suburban Diagnostics India Pvt.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suburban-diagnostics-india-pvt

- Industry: Healthcare
- Headquarters: Mumbai, India
- Website: www.suburbandiagnostics.com
- Total disclosed funding: $7.4M
- Latest round: Series C (Apr 5, 2016)
- Investors on record: 1

## About

Suburban Diagnostics India Pvt. Ltd. offers advanced diagnostic services, specializing in laboratory tests to support clinical and preventive healthcare, enhancing the accuracy of patient diagnosis and treatment planning.Suburban Diagnostics India Pvt. Ltd. is focused on providing diagnostic services in Mumbai, India, and was founded in 1994 by Sanjay Arora. The company has undergone significant growth since its establishment, completing five deals, and has received funding from Sequoia Capital. In 2021, the company participated in a funding round raising USD 7.00 mn, bringing the total amount raised to USD 7.00 mn. The company is noted for its diagnostic solutions, vital for healthcare institutions.Suburban Diagnostics specializes in advanced diagnostic services, providing a wide array of laboratory tests that cater to clinical and preventive healthcare needs. Core offerings include pathology, radiology, and genetic testing, aimed at aiding healthcare professionals in patient diagnosis and treatment planning. Their services are utilized across hospitals, outpatient clinics, and private practices, ensuring access to essential health insights. The tests are engineered for precision and quick results, which helps improve patient care and turnaround time.Suburban Diagnostics generates revenue primarily through B2B transactions, partnering with healthcare institutions and providers for diagnostic services. The approach includes contract-based agreements with hospitals and clinics, implementing tiered pricing for bulk testing. For the most recent year, 2024, the company reported a revenue of USD 19.82 mn and an EBITDA of USD 2.69 mn, driven by its flagship offerings in specialized tests and comprehensive screening solutions.Suburban Diagnostics is poised for future growth by expanding its product offerings and exploring new markets. Although details on specific new products are yet to be disclosed, the company aims to develop additional diagnostic services. The strategic focus includes entering new geographic regions, particularly in urban centers across North America and Europe, targeting expansion plans by 2024. The recent funding of USD 7.00 mn will be strategically utilized to support these initiatives. In October 2021, Dr Lal Pathlabs agreed to acquire Suburban Diagnostics India Pvt. Ltd. from Sequoia Capital, which may further influence its growth trajectory.

## Funding rounds

- Series C, Apr 5, 2016, $5.6M — Hong Shan
- Series B, Dec 16, 2014, $1.8M — Hong Shan

## Investors

- Hong Shan — Series B, Series C